These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 17018609)

  • 21. MLK3 is critical for breast cancer cell migration and promotes a malignant phenotype in mammary epithelial cells.
    Chen J; Miller EM; Gallo KA
    Oncogene; 2010 Aug; 29(31):4399-411. PubMed ID: 20514022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HOXB7: a key factor for tumor-associated angiogenic switch.
    Carè A; Felicetti F; Meccia E; Bottero L; Parenza M; Stoppacciaro A; Peschle C; Colombo MP
    Cancer Res; 2001 Sep; 61(17):6532-9. PubMed ID: 11522651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ESX induces transformation and functional epithelial to mesenchymal transition in MCF-12A mammary epithelial cells.
    Schedin PJ; Eckel-Mahan KL; McDaniel SM; Prescott JD; Brodsky KS; Tentler JJ; Gutierrez-Hartmann A
    Oncogene; 2004 Mar; 23(9):1766-79. PubMed ID: 14767472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression.
    Huber MA; Azoitei N; Baumann B; Grünert S; Sommer A; Pehamberger H; Kraut N; Beug H; Wirth T
    J Clin Invest; 2004 Aug; 114(4):569-81. PubMed ID: 15314694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer.
    Buijs JT; Henriquez NV; van Overveld PG; van der Horst G; Que I; Schwaninger R; Rentsch C; Ten Dijke P; Cleton-Jansen AM; Driouch K; Lidereau R; Bachelier R; Vukicevic S; Clézardin P; Papapoulos SE; Cecchini MG; Löwik CW; van der Pluijm G
    Cancer Res; 2007 Sep; 67(18):8742-51. PubMed ID: 17875715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
    Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
    Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells.
    Krop IE; Sgroi D; Porter DA; Lunetta KL; LeVangie R; Seth P; Kaelin CM; Rhei E; Bosenberg M; Schnitt S; Marks JR; Pagon Z; Belina D; Razumovic J; Polyak K
    Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9796-801. PubMed ID: 11481438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors.
    Amemiya Y; Yang W; Benatar T; Nofech-Mozes S; Yee A; Kahn H; Holloway C; Seth A
    Breast Cancer Res Treat; 2011 Apr; 126(2):373-84. PubMed ID: 20464481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects.
    Tobin SW; Douville K; Benbow U; Brinckerhoff CE; Memoli VA; Arrick BA
    Oncogene; 2002 Jan; 21(1):108-18. PubMed ID: 11791181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
    Zhang H; Stephens LC; Kumar R
    Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fra-1 regulates vimentin during Ha-RAS-induced epithelial mesenchymal transition in human colon carcinoma cells.
    Andreolas C; Kalogeropoulou M; Voulgari A; Pintzas A
    Int J Cancer; 2008 Apr; 122(8):1745-56. PubMed ID: 18098284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Galectin-8 induces partial epithelial-mesenchymal transition with invasive tumorigenic capabilities involving a FAK/EGFR/proteasome pathway in Madin-Darby canine kidney cells.
    Oyanadel C; Holmes C; Pardo E; Retamal C; Shaughnessy R; Smith P; Cortés P; Bravo-Zehnder M; Metz C; Feuerhake T; Romero D; Roa JC; Montecinos V; Soza A; González A
    Mol Biol Cell; 2018 Mar; 29(5):557-574. PubMed ID: 29298841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-throughput mRNA and miRNA profiling of epithelial-mesenchymal transition in MDCK cells.
    Shukla P; Vogl C; Wallner B; Rigler D; Müller M; Macho-Maschler S
    BMC Genomics; 2015 Nov; 16():944. PubMed ID: 26572553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ras-induced modulation of CXCL10 and its receptor splice variant CXCR3-B in MDA-MB-435 and MCF-7 cells: relevance for the development of human breast cancer.
    Datta D; Flaxenburg JA; Laxmanan S; Geehan C; Grimm M; Waaga-Gasser AM; Briscoe DM; Pal S
    Cancer Res; 2006 Oct; 66(19):9509-18. PubMed ID: 17018607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PRRX2 as a novel TGF-β-induced factor enhances invasion and migration in mammary epithelial cell and correlates with poor prognosis in breast cancer.
    Juang YL; Jeng YM; Chen CL; Lien HC
    Mol Carcinog; 2016 Dec; 55(12):2247-2259. PubMed ID: 26824226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Notch1 induces epithelial-mesenchymal transition and the cancer stem cell phenotype in breast cancer cells and STAT3 plays a key role.
    Zhang X; Zhao X; Shao S; Zuo X; Ning Q; Luo M; Gu S; Zhao X
    Int J Oncol; 2015 Mar; 46(3):1141-8. PubMed ID: 25544568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PRL-3 down-regulates PTEN expression and signals through PI3K to promote epithelial-mesenchymal transition.
    Wang H; Quah SY; Dong JM; Manser E; Tang JP; Zeng Q
    Cancer Res; 2007 Apr; 67(7):2922-6. PubMed ID: 17409395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eps8 regulates cellular proliferation and migration of breast cancer.
    Chen C; Liang Z; Huang W; Li X; Zhou F; Hu X; Han M; Ding X; Xiang S
    Int J Oncol; 2015 Jan; 46(1):205-14. PubMed ID: 25333707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MEK1 signaling mediates transformation and metastasis of EpH4 mammary epithelial cells independent of an epithelial to mesenchymal transition.
    Pinkas J; Leder P
    Cancer Res; 2002 Aug; 62(16):4781-90. PubMed ID: 12183438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of endoplasmic reticulum protein 29 regulates mesenchymal-epithelial transition and suppresses xenograft tumor growth of invasive breast cancer cells.
    Bambang IF; Xu S; Zhou J; Salto-Tellez M; Sethi SK; Zhang D
    Lab Invest; 2009 Nov; 89(11):1229-42. PubMed ID: 19770839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.